Initiation of Isoniazid Prophylactic Therapy among Newly Diagnosed HIV-Positive Persons in Three High HIV-Burden Districts of South Africa
- 1 Howard University Global Initiative, Johannesburg, South Africa
- 2 Howard University Global Initiative, Johannesburg, South Africa
- 3 Howard University Global Initiative, Johannesburg, South Africa
- 4 Howard University Global Initiative, Johannesburg, South Africa
- 5 US Centers for Disease Control and Prevention, Johannesburg, South Africa
- 6 US Centers for Disease Control and Prevention, Johannesburg, South Africa
- 7 US Centers for Disease Control and Prevention, Johannesburg, South Africa
- 8 Howard University Global Initiative, Johannesburg, South Africa
Abstract
Background: South Africa is experiencing the worst HIV-driven tuberculosis (TB) epidemic in the world. More than 300,000 new cases of active TB are reported in the country each year with 60% co-infected with HIV. Isoniazid preventive therapy (IPT) is a key public health intervention for the prevention of TB among people living with HIV (PLHIV) and is recommended as part of a comprehensive HIV and AIDS care strategy. However, program data suggests that coverage of IPT service to be very low. This study aims to assess IPT initiation rate among newly diagnosed HIV-positive persons in three high HIV-burden districts of South Africa. Methods: A cross-sectional study was conducted using routine data generated from pre-ART and ART programs in 35 purposively selected primary health care (PHC) clinics in South Africa. The facilities were selected from three high HIV-burden districts with a mix of urban and rural settings. TB screening and IPT initiation status was assessed within a window period of one-year post HIV diagnosis. Initiation rate of IPT services among newly diagnosed HIV-positive persons was assessed. The chi-squared test was used to determine whether there was a significant difference in the proportion of newly diagnosed HIV-positive persons who were initiated on IPT by sex, age group, pregnancy status, health facility, district and location of facility. Results: We identified 12,413 newly diagnosed HIV patients aged 12-years-old and above between June 1, 2014 and March 31, 2015. TB screening was not conducted among 33% of newly diagnosed HIV-positive persons to rule out or confirm the presence of active TB. IPT was initiated in 42.2% of known IPT-eligible HIV-positive persons. Initiation of IPT services was lower in younger patients aged 12 to 20-years-old compared to older patients. The proportion of pregnant women who were initiated on IPT was higher compared to the proportion in non-pregnant women (51.0% and 40.1% respectively; P < 0.05). Health care clinics located in uThukela health district registered the highest initiation rates of IPT care (48.1%; CI: 46.2%, 50.1%) compared to clinics located in Gert Sibande (40.4%; CI: 38.7%, 42.2%) health district and Johannesburg Health District (38.5%; CI: 36.4%, 40.7%). Conclusion: This analysis shows that initiation rate of IPT services among newly diagnosed HIV positive persons was low in the 35 participating facilities during the period under investigation. There was variability in IPT initiation rates across the facilities included in this study and among different sub-groups of the study sample. This study has identified specific population groups and geographic settings that should be targeted by programs to improve IPT services. There is a need to identify factors that contributed to the low initiation rate of IPT services among young HIV positive persons, women with unrecorded pregnancy status and in facilities located in inner city of Johannesburg. Customized interventions tailored to the specific needs of facilities and population groups should be instituted to strengthen uptake of IPT services.
- United Nations (2014) United Nations Joint Programme on HIV/AIDS (UNAIDS) TGR.
- Shisana, O., Rehle, T., Simbayi, L., Zuma, K., Jooste, S. and Zungu, N. (2012) South African National HIV Prevalence, Incidence and Behavioural Survey. Human Science Research Council (HSRC) Cape Town, HSRC Press, Pretoria.
- Meintjes, G., Kerkhoff, A.D., Burton, R., Schutz, C., Boulle, A., Van Wyk, G., et al. (2015) HIV-Related Medical Admissions to a South African District Hospital Remain Frequent Despite Effective Antiretroviral Therapy Scale-Up. Medicine, 94, e2269. https://doi.org/10.1097/MD.0000000000002269
- World Health Organisation (2015) Global Tuberculosis Report 2015. World Health Organisation, France.
- World Health Organisation (2014) Global Tuberculosis Report 2014. World Health Organisation, France.
- National Department of Health (2014) National Consolidated Guidelines for the Prevention of Mother-to-Child Transmission of HIV (PMTCT) and the Management of HIV in Children Adolescents and Adults. National Department of Health, South Africa.
- Mindachew, M., Deriew, A., Memiah, P. and Biadgilign, S. (2014) Perceived Barriers to the Implementation of Isoniazid Preventive Therapy for People Living with HIV in Resource Constrained Settings. Pan African Medical Journal, 17, 2641. https://doi.org/10.11604/pamj.2014.17.26.2641
- Golub, J.E., Lerato, M., Nkeko, T. and Mosa, M. (2009) Isoniazid Preventive Therapy, HAART and Tuberculosis Risk in HIV-Infected Adults in South Africa: A Prospective Cohort. AIDS, 23, 631-636. https://doi.org/10.1097/QAD.0b013e328327964f
- Akolo, C., Bada, F. and Okpokoro, E. (2015) Debunking the Myths Perpetuating Low Implementation of Isoniazid Preventive Therapy amongst Human Immunodeficiency Virus-Infected Persons. World Journal of Virology, 4, 105 -112. https://doi.org/10.5501/wjv.v4.i2.105
- National Department of Health (2010) Guidelines for Tuberculosis Preventive Therapy among HIV Infected Individuals. National Department of Health, South Africa.
- Raizada, N., Chauhan, L.S., Babu, B.S., Thakur, R., Khera, A., Wares, F.D., et al. (2009) Linking HIV infected TB patients to Cotrimoxazole Prophylaxis and Antiretroviral Treatment in India. PLoS ONE, 4, e5999. https://doi.org/10.1371/journal.pone.0005999
- World Health Organisation (2015) Global Health Sector Response to HIV, 2000-2015 Focus on Innovations in Africa. World Health Organisation, France.